학술논문

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
Document Type
Article
Source
In The Lancet 20-26 April 2024 403(10436):1563-1573
Subject
Primary Research
Articles
Language
ISSN
0140-6736